This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

U.S. Federal Trade Commission: FTC approves final order settling charges that Grifols, S.A.’s acquisition of Talecris Biotherapeutics Holding Corp. was anticompetitive

( July 22, 2011, 15:28 GMT | Official Statement) -- MLex Summary: The Federal Trade Commission has issued this statement approving its final order, after the closing of the comment period, settling charges that Grifols' acquisition of Talecris was anticompetitive and required the sale of Talecris' facility in Melville and Grifols' assets to competitor Kedrion. FTC press release follows in full:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login